Note*: This report requires 7-10 business days to complete.
DelveInsight’s Atrial Fibrillation - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Atrial Fibrillation forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Atrial Fibrillation till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Atrial Fibrillation market.
• Identifying patient populations in the global “Atrial Fibrillationmarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Atrial Fibrillation therapeutics in each of the markets covered.
• To understand the future market competition in the global Atrial Fibrillation therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Atrial Fibrillation for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Atrial Fibrillation overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Atrial Fibrillation Market
• Global Epidemiology of Atrial Fibrillation Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Atrial Fibrillation Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Atrial Fibrillation (2013-2023)
• Table 7: Atrial Fibrillation Global Market (USD Millions), (2013-2015)
• Table 8: Atrial Fibrillation Global Market (USD Millions), (2016-2023)
• Table 9: Atrial Fibrillation US Market (USD Millions), (2013-2015)
• Table 10: Atrial Fibrillation US Market (USD Millions), (2016-2023)
• Table 11: Atrial Fibrillation Germany Market (USD Millions), (2013-2015)
• Table 12: Atrial Fibrillation Germany Market (USD Millions), (2016-2023)
• Table 13: Atrial Fibrillation United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Atrial Fibrillation United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Atrial Fibrillation France Market (USD Millions), (2013-2015)
• Table 16: Atrial Fibrillation France Market (USD Millions), (2016-2023)
• Table 17: Atrial Fibrillation Italy Market (USD Millions), (2013-2015)
• Table 18: Atrial Fibrillation Italy Market (USD Millions), (2016-2023)
• Table 19: Atrial Fibrillation Spain Market (USD Millions), (2013-2015)
• Table 20: Atrial Fibrillation Spain Market (USD Millions), (2016-2023)
• Table 21: Atrial Fibrillation Japan Market (USD Millions), (2013-2015)
• Table 22: Atrial Fibrillation Japan Market (USD Millions), (2016-2023)
• Table 23: Atrial Fibrillation ROW Market (USD Millions), (2013-2015)
• Table 24: Atrial Fibrillation ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Atrial Fibrillation Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Atrial Fibrillation (2013-2023)
• Figure 3: Atrial Fibrillation Global Market (USD Millions), (2013-2015)
• Figure 4: Atrial Fibrillation Global Market (USD Millions), (2016-2023)
• Figure 5: Atrial Fibrillation US Market (USD Millions), (2013-2015)
• Figure 6: Atrial Fibrillation US Market (USD Millions), (2016-2023)
• Figure 7: Atrial Fibrillation Germany Market (USD Millions), (2013-2015)
• Figure 8: Atrial Fibrillation Germany Market (USD Millions), (2016-2023)
• Figure 9: Atrial Fibrillation United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Atrial Fibrillation United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Atrial Fibrillation France Market (USD Millions), (2013-2015)
• Figure 12: Atrial Fibrillation France Market (USD Millions), (2016-2023)
• Figure 13: Atrial Fibrillation Italy Market (USD Millions), (2013-2015)
• Figure 14: Atrial Fibrillation Italy Market (USD Millions), (2016-2023)
• Figure 15: Atrial Fibrillation Spain Market (USD Millions), (2013-2015)
• Figure 16: Atrial Fibrillation Spain Market (USD Millions), (2016-2023)
• Figure 17: Atrial Fibrillation Japan Market (USD Millions), (2013-2015)
• Figure 18: Atrial Fibrillation Japan Market (USD Millions), (2015-2023)
• Figure 19: Atrial Fibrillation ROW Market (USD Millions), (2013-2015)
• Figure 20: Atrial Fibrillation ROW Market (USD Millions), (2016-2023)
• ARCA biopharma Inc.
• Armetheon Inc.
• AstraZeneca Plc
• Bristol-Myers Squibb Company
• Cardiome Pharma Corp.
• Daiichi Sankyo Company Limited
• Gilead Sciences Inc.
• Isis Pharmaceuticals Inc.
• Laboratoires Pierre Fabre SA
• Nissan Chemical Industries Ltd.
• Nyken BV
• Otsuka Holdings Co. Ltd.
• Xention Limited
